• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无细胞DNA检测结果异常后的妊娠结局调查。

Investigating Pregnancy Outcomes After Abnormal Cell-Free DNA Test Results.

作者信息

Lu Jessica, Saller Devereux N, Fraer Luanne M, Chen Beatrice A

机构信息

Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine, 300 Halket St, Pittsburgh, PA, 15213, USA.

Magee-Womens Research Institute, 204 Craft Ave, Pittsburgh, PA, 15213, USA.

出版信息

J Genet Couns. 2018 Aug;27(4):902-908. doi: 10.1007/s10897-018-0219-7. Epub 2018 Jan 24.

DOI:10.1007/s10897-018-0219-7
PMID:29368276
Abstract

Cell-free DNA (cfDNA) testing has increased sensitivity and specificity compared to other prenatal screening methods, but invasive diagnostic testing (IDT) is recommended for confirmation. We performed a retrospective chart review of 39 women with abnormal cfDNA results between March 2012 and September 2015 at an urban academic hospital to evaluate patient choice and pregnancy outcomes. We analyzed data using descriptive statistics, Fisher's exact tests, and Wilcoxon rank-sum tests. Median maternal age was 36.0 years [interquartile range (IQR) 31, 39]; 64.1% of women (25/39) were advanced maternal age and 69.2% (27/39) had abnormal ultrasounds. Median gestational age at time of cfDNA testing was 18 3/7 weeks [IQR 12 2/7, 20 5/7]. cfDNA results included trisomy 21 (89.7%, 35/39), trisomy 18 (7.7%, 3/39), and both trisomy 21/monosomy X (2.6%, 1/39). Of 39 women, 22 (56.4%) continued and 10 (25.6%) terminated the pregnancy; six (15.4%) had fetal demises, and one was lost to follow-up. Of women continuing their pregnancies, 54.6% (12/22) declined further genetic counseling, and 77.3% (17/22) declined IDT. Only 14 women pursued IDT; not pursuing IDT was associated with continuing the pregnancy (Fisher's exact test, p = .001). All women terminating their pregnancy (90.0%, 9/10) pursued IDT or had major anomalies on ultrasound, suggesting that women considering termination undergo more confirmatory tests or already have high suspicion for an abnormal pregnancy.

摘要

与其他产前筛查方法相比,游离DNA(cfDNA)检测的敏感性和特异性有所提高,但仍建议采用侵入性诊断检测(IDT)进行确诊。我们对2012年3月至2015年9月期间在一家城市学术医院cfDNA检测结果异常的39名女性进行了回顾性病历审查,以评估患者的选择和妊娠结局。我们使用描述性统计、Fisher精确检验和Wilcoxon秩和检验分析数据。产妇年龄中位数为36.0岁[四分位间距(IQR)31,39];64.1%的女性(25/39)为高龄产妇,69.2%(27/39)超声检查异常。cfDNA检测时的孕周中位数为18 3/7周[IQR 12 2/7,20 5/7]。cfDNA检测结果包括21三体(89.7%,35/39)、18三体(7.7%,3/39)以及21三体/单体X(2.6%,1/39)。39名女性中,22名(56.4%)继续妊娠,10名(25.6%)终止妊娠;6名(15.4%)发生胎儿死亡,1名失访。继续妊娠的女性中,54.6%(12/22)拒绝进一步的遗传咨询,77.3%(17/22)拒绝IDT。只有14名女性接受了IDT;未接受IDT与继续妊娠相关(Fisher精确检验,p = 0.001)。所有终止妊娠的女性(90.0%,9/10)均接受了IDT或超声检查发现严重异常,这表明考虑终止妊娠的女性会接受更多的确诊检查或已经高度怀疑妊娠异常。

相似文献

1
Investigating Pregnancy Outcomes After Abnormal Cell-Free DNA Test Results.无细胞DNA检测结果异常后的妊娠结局调查。
J Genet Couns. 2018 Aug;27(4):902-908. doi: 10.1007/s10897-018-0219-7. Epub 2018 Jan 24.
2
Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA).无创产前筛查游离DNA(cfDNA)检测结果为非整倍体阳性后的患者选择及临床结局
Prenat Diagn. 2016 May;36(5):456-62. doi: 10.1002/pd.4805. Epub 2016 Apr 7.
3
Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.母体外周血游离 DNA 检测筛查三体的结果失败:后果分析。
Ultrasound Obstet Gynecol. 2016 Jun;47(6):698-704. doi: 10.1002/uog.15851. Epub 2016 Apr 25.
4
Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.在丹麦临床环境中使用游离胎儿 DNA 进行有条件的早孕期筛查非整倍体。
Ultrasound Obstet Gynecol. 2018 Apr;51(4):470-479. doi: 10.1002/uog.17562. Epub 2018 Mar 4.
5
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
6
Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21: A Randomized Clinical Trial.基于游离 DNA 筛查与直接有创诊断对 21-三体综合征高危妊娠孕妇流产率影响的随机临床试验
JAMA. 2018 Aug 14;320(6):557-565. doi: 10.1001/jama.2018.9396.
7
Clinical utility of non-invasive prenatal testing in pregnancies with ultrasound anomalies.超声异常妊娠中非侵入性产前检测的临床应用价值
Ultrasound Obstet Gynecol. 2017 Jun;49(6):721-728. doi: 10.1002/uog.17228.
8
Clinical Practice Guidelines for Prenatal Aneuploidy Screening and Diagnostic Testing from Korean Society of Maternal-Fetal Medicine: (1) Prenatal Aneuploidy Screening.韩国母胎医学会产前非整倍体筛查和诊断检测临床实践指南:(1)产前非整倍体筛查。
J Korean Med Sci. 2021 Jan 25;36(4):e27. doi: 10.3346/jkms.2021.36.e27.
9
Cell-free DNA test for fetal chromosomal abnormalities in multiple pregnancies.游离胎儿 DNA 检测在多胎妊娠胎儿染色体异常中的应用。
Acta Obstet Gynecol Scand. 2024 Sep;103(9):1799-1807. doi: 10.1111/aogs.14901. Epub 2024 Jun 25.
10
Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.双胎妊娠胎儿三体的常规早孕期筛查:游离 DNA 检测取决于联合检测的结果。
Ultrasound Obstet Gynecol. 2019 Feb;53(2):208-213. doi: 10.1002/uog.20160. Epub 2018 Dec 7.

本文引用的文献

1
Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders.实践公告第 162 号:遗传疾病的产前诊断检测。
Obstet Gynecol. 2016 May;127(5):e108-e122. doi: 10.1097/AOG.0000000000001405.
2
Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting.女性的观点以及无创产前检测对管理式医疗环境中医疗程序的影响。
Prenat Diagn. 2015 May;35(5):428-33. doi: 10.1002/pd.4495. Epub 2014 Sep 30.
3
The decision to continue a pregnancy affected by Down syndrome: timing of decision and satisfaction with receiving a prenatal diagnosis.
关于继续妊娠唐氏综合征患儿的决定:决定时机及对接受产前诊断的满意度
J Genet Couns. 2013 Oct;22(5):587-93. doi: 10.1007/s10897-013-9590-6. Epub 2013 Apr 21.
4
Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening.接受无创性产前检测(NIPT)的女性在阳性非整倍体筛查后的情况。
Prenat Diagn. 2013 Jun;33(6):542-6. doi: 10.1002/pd.4125.
5
Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities.产前诊断胎儿染色体异常后影响终止妊娠的相关因素。
J Genet Couns. 2013 Apr;22(2):238-48. doi: 10.1007/s10897-012-9539-1. Epub 2012 Sep 23.
6
Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18.母体外周血循环肿瘤细胞游离 DNA 染色体选择性测序在早孕期 21-三体和 18-三体检测中的应用。
Am J Obstet Gynecol. 2012 Apr;206(4):322.e1-5. doi: 10.1016/j.ajog.2012.01.029. Epub 2012 Jan 24.
7
Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing.基于母体外周血游离 DNA 测序的全基因组胎儿非整倍体检测
Obstet Gynecol. 2012 May;119(5):890-901. doi: 10.1097/AOG.0b013e31824fb482.
8
Meeting patients' education and decision-making needs for first trimester prenatal aneuploidy screening.满足患者对早孕期产前非整倍体筛查的教育和决策需求。
Prenat Diagn. 2011 Dec;31(13):1222-8. doi: 10.1002/pd.2867. Epub 2011 Oct 24.
9
DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study.母体外周血游离 DNA 测序用于唐氏综合征的检测:一项国际临床验证研究。
Genet Med. 2011 Nov;13(11):913-20. doi: 10.1097/GIM.0b013e3182368a0e.
10
Parental decisions regarding a prenatally detected fetal chromosomal abnormality and the impact of genetic counseling: an analysis of 38 cases with aneuploidy in Southeast Turkey.父母关于产前检测到的胎儿染色体异常的决策以及遗传咨询的影响:对土耳其东南部38例非整倍体病例的分析
J Genet Couns. 2010 Jun;19(3):241-6. doi: 10.1007/s10897-009-9275-3. Epub 2010 Jan 30.